The antiphospholipid-protein syndrome (Q40977408)

25 September 2017

1 reference

title

The antiphospholipid-protein syndrome (English)

1 reference

25 September 2017

Cines DB

1

1 reference

PubMed ID

8613497

25 September 2017

McCrae KR

series ordinal

2

1 reference

25 September 2017

1 November 1995

1 reference

Journal of Clinical Immunology

25 September 2017

1 reference

25 September 2017

15

1 reference

25 September 2017

6 Suppl

1 reference

25 September 2017

86S-100S

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01540898

25 September 2017

0 references

cites work

The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF01540898

Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01540898

In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01540898

Regulatory effect of antiphospholipid antibodies on signal transduction: a possible model for autoantibody-induced reproductive failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01540898

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01540898

Factors that predict antiphospholipid immunoreactivity in young people with transient focal neurological events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01540898

Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01540898

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01540898

Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01540898

Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01540898

A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection

21 January 2018

1 reference

12 December 2020

Characterization of urokinase receptor expression by human placental trophoblasts

1 reference

12 December 2020

Autoantibodies to thrombomodulin: development of an enzyme immunoassay and a survey of their frequency in patients with the lupus anticoagulant

1 reference

12 December 2020

Interaction of heparin with beta 2-glycoprotein I and antiphospholipid antibodies in vitro

1 reference

12 December 2020

Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein

1 reference

12 December 2020

The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S

1 reference

12 December 2020

Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience

1 reference

12 December 2020

Activity, disulphide mapping and structural modelling of the fifth domain of human beta 2-glycoprotein I

1 reference

12 December 2020

Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells

1 reference

12 December 2020

Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity--studies in a thrombosis model

1 reference

12 December 2020

Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies

1 reference

12 December 2020

A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies

1 reference

12 December 2020

Prolonged bleeding time in patients with lupus anticoagulant

1 reference

12 December 2020

Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders

1 reference

12 December 2020

The immunoglobulin G fraction from plasma containing antiphospholipid antibodies causes increased placental thromboxane production

1 reference

12 December 2020

Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome

1 reference

12 December 2020

Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study

1 reference

12 December 2020

Beta 2-glycoprotein I deficiency and the risk of thrombosis

1 reference

12 December 2020

Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I

1 reference

12 December 2020

Neutralization of lupus anticoagulant activity by human immunoglobulin "in vitro"

1 reference

12 December 2020

Functional protein S in women with lupus anticoagulant inhibitor

1 reference

12 December 2020

Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Studies in a perfusion system

1 reference

12 December 2020

Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells

1 reference

12 December 2020

Antiphospholipid cofactor

1 reference

12 December 2020

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

1 reference

12 December 2020

Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?

1 reference

12 December 2020

Some antiphospholipid antibodies inhibit phospholipase A2 activity

1 reference

12 December 2020

Intravenous immunoglobulin treatment of women with multiple miscarriages

1 reference

12 December 2020

Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura

1 reference

12 December 2020

Thromboxane dominance and prostacyclin deficiency in habitual abortion

1 reference

12 December 2020

The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosus

1 reference

12 December 2020

In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanism

1 reference

12 December 2020

Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production

1 reference

12 December 2020

Anti-phospholipid antibodies and pregnancy loss

1 reference

12 December 2020

Presence of a 16/6 related human anti-DNA common idiotype (SA1) in the anticardiolipin antibodies of patients with primary antiphospholipid syndrome

1 reference

12 December 2020

Antiphospholipid syndrome: five year follow up

1 reference

12 December 2020

Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies

1 reference

12 December 2020

Molecular definition of human beta 2-glycoprotein I (beta 2-GPI) by cDNA cloning and inter-species differences of beta 2-GPI in alternation of anticardiolipin binding

1 reference

12 December 2020

Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin

1 reference

12 December 2020

In vitro studies of antiphospholipid antibodies and its cofactor, beta 2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation

1 reference

12 December 2020

Antiendothelial Cell Antibodies in Patients with the Antiphospholipid Syndrome

1 reference

12 December 2020

Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid antibodies, and the antiphospholipid syndrome

1 reference

12 December 2020

Immunology and Clinical Importance of Antiphospholipid Antibodies

1 reference

12 December 2020

Sulfated glycolipids are the platelet autoantigens for human platelet-binding monoclonal anti-DNA autoantibodies

1 reference

12 December 2020

Prevalence of antiphospholipid antibodies in patients with fetal loss

1 reference

12 December 2020

Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients

1 reference

12 December 2020

Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study

1 reference

12 December 2020

The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant

1 reference

12 December 2020

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

1 reference

12 December 2020

Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen

1 reference

12 December 2020

Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant

1 reference

12 December 2020

Should anticardiolipin tests be performed in otherwise healthy pregnant women?

1 reference

12 December 2020

Transbilayer movement of phospholipids in red cell and platelet membranes

1 reference

12 December 2020

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

12 December 2020

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

12 December 2020

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

1 reference

12 December 2020

Antibodies to platelets in patients with anti-phospholipid antibodies

1 reference

12 December 2020

Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis

1 reference

12 December 2020

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

12 December 2020

Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo

1 reference

12 December 2020

Inhibition of the tissue factor-factor VII mediated activation of coagulation factor X by a monoclonal IgM antibody expressing lupus anticoagulant activity

1 reference

12 December 2020

Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets

1 reference

12 December 2020

Antiphospholipid antibodies and cerebral ischemia in young people

1 reference

12 December 2020

Reactivities of antiphospholipid antibodies to blood cells and their effects on platelet aggregations in vitro

1 reference

12 December 2020

Partial neutralization of a lupus anticoagulant by human immunoglobulin

1 reference

12 December 2020

Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

1 reference

12 December 2020

Total and free protein S in systemic lupus erythematosus

1 reference

12 December 2020

Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin

1 reference

12 December 2020

Studies of natural anticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant

1 reference

12 December 2020

Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss

1 reference

12 December 2020

Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus

1 reference

12 December 2020

Cytotoxic antibody against trophoblast and lymphocytes present in pregnancy with intrauterine fetal growth retardation and its relation to anti-phospholipid antibody

1 reference

12 December 2020

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

12 December 2020

Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin

1 reference

12 December 2020

Anti-prothrombin antibodies and the lupus anticoagulant

1 reference

12 December 2020

Intravenous gamma-globulin, antiphospholipid antibodies, and pregnancy

1 reference

12 December 2020

Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation.

1 reference

12 December 2020

Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant

1 reference

12 December 2020

Effect of the lupus anticoagulant on endothelial fibrinolytic activity in vitro

1 reference

12 December 2020

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

1 reference

12 December 2020

Inhibition of phospholipid and platelet-dependent prothrombinase activity in the plasma of patients with lupus anticoagulants

1 reference

12 December 2020

Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant

1 reference

12 December 2020

The "primary" antiphospholipid syndrome: major clinical and serological features.

1 reference

12 December 2020

Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cells

1 reference

12 December 2020

Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases

1 reference

12 December 2020

Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin

1 reference

12 December 2020

Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome.

1 reference

12 December 2020

Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation

1 reference

12 December 2020

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

1 reference

12 December 2020

IgG binding to endothelial cells in systemic lupus erythematosus

1 reference

12 December 2020

Placental abnormalities in systemic lupus erythematosus: in situ deposition of antinuclear antibodies

1 reference

12 December 2020

Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels

1 reference

12 December 2020

An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis

1 reference

12 December 2020

Kallikrein inhibition and C1-esterase inhibitor levels in patients with the lupus inhibitor

1 reference

12 December 2020

Prognosis of subsequent pregnancies after recurrent spontaneous abortion in first trimester

1 reference

12 December 2020

Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies.

1 reference

12 December 2020

Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity

1 reference

12 December 2020

Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis

1 reference

12 December 2020

Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant

1 reference

12 December 2020

Anti-idiotypic antibodies against anti-phospholipid autoantibodies which suppress lupus-like anticoagulant activity

1 reference

12 December 2020

Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis

1 reference

12 December 2020

Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization

1 reference

12 December 2020

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

1 reference

12 December 2020

Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus.

1 reference

12 December 2020

Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems

1 reference

12 December 2020

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

1 reference

12 December 2020

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

1 reference

12 December 2020

Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation

1 reference

12 December 2020

Characterization of plasma lipids and lipoproteins in patients with beta 2-glycoprotein I (apolipoprotein H) deficiency.

1 reference

12 December 2020

SLE anticoagulant: transient inhibition by high dose immunoglobulin infusions

1 reference

12 December 2020

beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway

1 reference

12 December 2020

Platelet binding properties of monoclonal lupus autoantibodies produced by human hybridomas.

1 reference

12 December 2020

Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal

1 reference

12 December 2020

Thromboembolism in patients with the 'lupus'-type circulating anticoagulant

1 reference

12 December 2020

A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome

1 reference

12 December 2020

Inhibition of platelet prothrombinase activity by a lupus anticoagulant

1 reference

12 December 2020

Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors

1 reference

12 December 2020

Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies

1 reference

12 December 2020

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

12 December 2020

Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis

1 reference

12 December 2020

"Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation

1 reference

12 December 2020

Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity

1 reference

12 December 2020

Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis

1 reference

12 December 2020

The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies.

1 reference

12 December 2020

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

1 reference

12 December 2020

Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding

1 reference

12 December 2020

Detection of antitrophoblast antibodies in the sera of patients with anticardiolipin antibodies and fetal loss

1 reference

12 December 2020

Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects

1 reference

12 December 2020

Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects

1 reference

12 December 2020

Inhibition of prothrombin activation by antiphospholipid antibodies and beta 2-glycoprotein 1

1 reference

12 December 2020

Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies.

1 reference

12 December 2020

Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody

1 reference

12 December 2020

Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism

1 reference

12 December 2020

Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study

1 reference

12 December 2020

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

1 reference

12 December 2020

Antibodies to beta 2-glycoprotein I inhibit phospholipid dependent coagulation reactions

1 reference

12 December 2020

Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation

1 reference

12 December 2020

Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?

1 reference

12 December 2020

Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

1 reference

12 December 2020

Functional and binding studies of the roles of prothrombin and beta 2-glycoprotein I in the expression of lupus anticoagulant activity

1 reference

12 December 2020

Elution of anticardiolipin antibodies and their cofactor beta 2-glycoprotein 1 from the placentae of patients with a poor obstetric history.

1 reference

12 December 2020

Protein S deficiency associated to anti-protein S antibodies in a patient with mixed connective-tissue disease and its reversal by danazol

1 reference

12 December 2020

Anticoagulant activity of an anti-beta 2-glycoprotein I antibody is dependent on the presence of beta 2-glycoprotein I

1 reference

12 December 2020

Do patients with antiphospholipid syndrome have autoantibodies to beta 2-glycoprotein I?

1 reference

12 December 2020

Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant

1 reference

12 December 2020

Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets

1 reference

12 December 2020

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment

1 reference

12 December 2020

Amino acid sequence of the region of beta 2-glycoprotein 1 (gp1) which mediates binding of autoantibodies to the cardiolipin-gp1 complex in humans

1 reference

12 December 2020

beta 2-Glycoprotein I-dependent and-independent anticardiolipin antibody in patients with end-stage renal disease

1 reference

12 December 2020

IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients

1 reference

12 December 2020

Primary antiphospholipid antibody syndrome and cerebral ischemia: report on acute intervention in two cases and literature review with emphasis on therapeutic options

1 reference

12 December 2020

Expression of human recombinant beta 2-glycoprotein I with anticardiolipin antibody cofactor activity

1 reference

12 December 2020

Antiphospholipid antibodies are not present in the membrane of gel-filtered platelets of patients with IgG anticardiolipin antibodies, lupus anticoagulant and thrombosis

1 reference

12 December 2020

Presence of serum antibodies to coagulation protein C in patients with systemic lupus erythematosus is not associated with antigenic or functional protein C deficiencies

1 reference

12 December 2020

Inhibitor(s) of natural anti-cardiolipin autoantibodies

1 reference

12 December 2020

Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone

1 reference

12 December 2020

Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis

1 reference

12 December 2020

Effect of anticardiolipin antibody in patients with recurrent fetal loss on thrombomodulin-dependent protein C activation

1 reference

12 December 2020

The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome

1 reference

12 December 2020

Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group

1 reference

12 December 2020

Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis

1 reference

12 December 2020

Beta 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants.

1 reference

12 December 2020

Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity

1 reference

12 December 2020

Protein S deficiency in men with long-term human immunodeficiency virus infection

1 reference

12 December 2020

Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3

1 reference

12 December 2020

Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles

1 reference

12 December 2020

Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort.

1 reference

12 December 2020

Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state

1 reference

12 December 2020

In vitro lupus anticoagulant neutralizing activity of intravenous immunoglobulin

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01540898

1 reference

PubMed ID

8613497

Dimensions Publication ID

25 September 2017

0 references

1 reference

PubMed ID

8613497